Pfizer explores sale of hospital drugs unit, sources say

Exclusive-Pfizer explores sale of hospital drugs unit, sources say
NEW YORK (Reuters) - Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter.
Pfizer said to be exploring sale of hospital drugs unit, Reuters reports
Pfizer (PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, Reuters’ Anirban Sen reports, citing people familiar with the matter.
Pfizer's Strategic Shift: Potential Sale of Hospital Drugs Unit
Pfizer is considering selling its hospital drugs unit, known as Pfizer Hospital, to reduce debt and streamline operations. This move follows pressure from activist investors and a history of large acquisitions.
Pfizer reportedly eyeing sale of hospital drugs unit
Pfizer (NYSE:PFE) has hired Goldman Sachs to gauge initial buyer interest as part of an attempt to sell its hospital drugs unit, Pfizer Hospital, potentially worth a few billion dollars, Reuters reported Tuesday, citing three people familiar with the matter.
Pfizer exploring sale of hospital drugs unit, Reuters reports
Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for
FiercePharma1d
Pfizer explores sale of hospital drugs unit amid activist investor’s call for accountability: Reuters
After a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to ...
devdiscourse1h
Pharma Updates: Amgen Overcomes Concerns, AstraZeneca Expands, and Pfizer Considers Sale
Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...
STAT1d
How Pfizer used wearables to tap into the promise of an experimental drug
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
Pfizer: The Tide Finally Turning
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
FierceBiotech1d
Centessa drops phase 2 hemophilia B drug in wake of Pfizer’s Hympavzi approval
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
3 Reasons Pfizer Looks Like a No-Brainer Buy Right Now
Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...
Keurig Dr Pepper hires ex-Pfizer CMO to lead beverage marketing
Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.
Hosted on MSN23h
Should Value Investors Buy Pfizer (PFE) Stock?
One company value investors might notice is Pfizer (PFE). PFE is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock is trading with a P/E ratio of 9.16, which compares to ...